How Long Will We Live in the 21st Century? Dr. Leonid A. Gavrilov, Ph.D. Dr. Nat ali a S. Gavr il ova, Ph.D. Center on Aging NORC and the University of Chicago Chicago, Illinois, USA
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 1/78
How Long Will We Live in t he
21st Cent ury?
Dr. Leonid A. Gavr ilov, Ph.D.
Dr. Natalia S. Gavr ilova, Ph.D.
Center on AgingNORC and the University of Chicago
Chicago, Illinois, USA
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 2/78
Trends in Life Expectancy at 60Females
Source: Human Mortality Database
17
19
21
23
25
27
29
L i f e
e x p e c t a n c
y
a t
6 0
USA
France
Ireland
GB
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 3/78
I n 2006 slow progress in lif e expectancyimprovement in t he Unit ed States
has been not iced
Mesle, F, Vall in , J. Diverging t rends in
female old-age mortalit y: The Unit edStates and t he Netherlands versusFrance and Japan.
. 2006.
NRC Panel on Diverging Mor talit y
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 4/78
New breakt hrough in
understanding and predict ing
human mort al i t y:Delayed effect s of smoking behavior aremuch more important t han previously
thought
Forecasting United Statesmortality using cohortsmoking histories. Wang
H, Preston SH. Proc Natl Acad Sci U S A . 2009 Jan13;106(2):393-8
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 5/78
Proport ion of deaths in di f ferentcauses due t o smoking
UK, 2000
Source: Murphy, Di Cesare. Presentation at the 2010 Annual Meeting of thePopulation Association of America, Dallas, TX.
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 6/78
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 7/78
Average number of years spent as a cigarette smoker before age 40 among men and womenin different birth cohorts.
Wang H , Preston S H PNAS 2009;106:393-398
©2009 by National Academy of Sciences
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 8/78
Probability of surviving from age 50 to 85 using different projection methods: United States,2004–2034.
Wang H , Preston S H PNAS 2009;106:393-398
©2009 by National Academy of Sciences
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 9/78
New Breakt hrough (2)
Most Recent References:
Contribution of Smoking to InternationalDifferences in Life Expectancy. by Samuel H.Preston, Dana A. Glei, and John R. Wilmoth. In:International Differences in Mortality at Older
Ages: Dimensions and Sources . US NationalResearch Council, The National Academies Press,2010.
http://www.nap.edu/catalog.php?record_id=12945 A new method for estimating smoking-attributable
mortality in high-income countries. Preston SH,Glei DA, Wilmoth JR. Int J Epidemiol . 2010
Apr;39(2):430-8.
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 10/78
The Fut ure (men)
The smoking epidemic among men has recededin nearly all industrialized countries.
In view of the lag between smoking behavior and
smoking-attributable mortality, it is reasonable toexpect that men in nearly all the study countrieswill benefit from reductions in the smoking-attributable fraction of deaths, thereby boosting
life expectancy.
Preston, Glei, Wilmoth. International Differences in Mortality at Older
Ages: Dimensions and Sources. NAS, 2010.
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 11/78
The Fut ure (w omen)
Among women, however, a later uptake of smoking has produced an upsurge in smoking-attributable deaths. In most countries in thisstudy, the prevalence of smoking among womenhas begun to decline, albeit much later than formen. But the effects of earlier increases havebeen playing a more powerful role in women's
mortality profiles and are likely to continue doingso for some time to come.
Preston, Glei, Wilmoth. International Differences in Mortality at Older Ages:
Dimensions and Sources. NAS, 2010.
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 12/78
New t rend: gender dif ferent ial inlife expectancy is narrow ing
Source: Glei, Horiuchi (2007), Population Studies, 61: 141 - 159
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 13/78
Gender dif ferent ial in LE at age 65
Source: Thorslund et al. Presentation at the REVES meeting in Havana
(2010).
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 14/78
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 15/78
Cancer Death Rates* Among Men, US,1930-2004
*Age-adjusted to the 2000 US standard population.
Source: US Mortality Data 1960-2004, US Mortality Volumes 1930-1959,National Center for Health Statistics, Centers for Disease Control and Prevention, 2006.
0
20
40
60
80
100
1 9 3 0
1 9 3 5
1 9 4 0
1 9 4 5
1 9 5 0
1 9 5 5
1 9 6 0
1 9 6 5
1 9 7 0
1 9 7 5
1 9 8 0
1 9 8 5
1 9 9 0
1 9 9 5
2 0 0 0
Lung & bronchus
Colon & rectum
Stomach
Rate Per 100,000
Prostate
Pancreas
LiverLeukemia
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 16/78
Cancer Death Rates* Among Women, US,1930-2004
*Age-adjusted to the 2000 US standard population.Source: US Mortality Data 1960-2004, US Mortality Volumes 1930-1959,National Center for Health Statistics, Centers for Disease Control and Prevention, 2006.
0
20
40
60
80
100
1 9 3 0
1 9 3 5
1 9 4 0
1 9 4 5
1 9 5 0
1 9 5 5
1 9 6 0
1 9 6 5
1 9 7 0
1 9 7 5
1 9 8 0
1 9 8 5
1 9 9 0
1 9 9 5
2 0 0 0
Lung & bronchus
Colon & rectum
Uterus
Stomach
Breast
Ovary
Pancreas
Rate Per 100,000
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 17/78
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 18/78
Cancer Incidence Rates* by Sex, US, 1975-2004
*Age-adjusted to the 2000 US standard population and adjusted for delays in reporting.Source: Surveillance, Epidemiology, and End Results Program, Delay-adjusted Incidence database:SEER Incidence Delay-adjusted Rates, 9 Registries, 1975-2004, National Cancer Institute, 2007.
0
100
200
300
400
500
600
700
1975 1978 1981 1984 1987 1990 1993 1996 1999 2002
Both Sexes
Men
Women
Rate Per 100,000
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 19/78
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 20/78
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 21/78
0
50
100
150
200
250
1965 1970 1975 1980 1985 1990 1995 2000 2005
A S R
( w o r l d ) p e r 1 0 0 , 0
0 0 USA (SEER)
England
Norway
Finland
Slovakia
The Netherlands
Japan (Osaka)
Breast cancer incidence rates (age 35-74) in selecteddeveloped countries
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 22/78
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 23/78
US advant age in cancerscreening and t reatment
Compared t o European count r ies, t he
US performs part icularly w ell int erms of cancer screening and cancersurvival. (Ho, Preston, 2010)
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 24/78
Change in the US Death Rates* by Cause,1950 & 2005
* Age-adjusted to 2000 US standard population.
Sources: 1950 Mortality Data - CDC/NCHS, NVSS, Mortality Revised.2005 Mortality Data: US Mortality Data 2005, NCHS, Centers for Disease Control and Prevention, 2008.
HeartDiseases
CerebrovascularDiseases
Influenza &Pneumonia
Cancer
1950
2005
Rate Per 100,000
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 25/78
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 26/78
Effect of Pharmaceut ical I nnovat ion onMortalit y, by Age
Source: Schnittker J, Karandinos G (2010). Social Science & Medicine.
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 27/78
Ranking of US age-specif ic death ratesamong a comparison set of 18 of OECD
count ries in 2005
OECD – Organization for Economic Cooperation and Development.
From Ho and Preston (2010)
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 28/78
US li fe expectancy at age 75has much bet t er ranking
among developed count r iescompared t o LE at age 50
“ Unusually vigorous deployment oflif e-saving t echnologies by t he UShealt h care syst em at very old age is
cont ribut ing to the age-pat t ern of USmortalit y rankings” (Ho, Preston, 2010
annual meeting of the Population Association of America, Dallas, TX)
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 29/78
Changes in female LE at age 65 in t he Unit ed
States betw een 1984 and 2000, by cause
In the U.S. gains in lifeexpectancy due to mortalityreduction from heart diseaseswere offset by mortalityincrease from mental
disorders, cancer, infectiousand respiratory diseases.
At the same time, France andJapan enjoyed total gain in LEof more than 2.5 years with
mortality reduction from almostall causes.
Mesle, Vallin, 2006. Populationand Development Review, 32:123-145.
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 30/78
Mortalit y at older ages may besensit ive t o many factors
Accessibi lit y and qualit y of medicalcare
Life st yle and proper nut ri t ion Social netw ork ing, et c.
Many r isk factors of m iddle age do
not w ork at older ages This may create divergent t rends in
different count ries and uncert aint y in
longevit y forecast s
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 31/78
Month of Birth
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
l i f e
e x p e c t a n c y a t a g e 8 0 , y e a r s
7.6
7.7
7.8
7.9
1885 Birth Cohort1891 Birth Cohort
Life Expectancy and Month of BirthData source :Social Security
Death Master File
Published in:
Gavrilova, N.S.,Gavrilov, L.A. Search
for Predictors ofExceptional HumanLongevity. In: “Living to 100 and Beyond ”Monograph. TheSociety of Actuaries,Schaumburg, Illinois,USA, 2005, pp. 1-49.
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 32/78
U.S. t rends in selected healt houtcomes (age 50+ )
Source: Goldman et al., National Tax Journal, 2010. Data from the National
Health Interview Survey
smoking
hypertension
obesity
diabetes
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 33/78
Obesity
Receives now t he most at t ent ion of
polit icians and mass media
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 34/78
Trends in Overweight* Prevalence (%), Adults 18 and Older, US,1992-2006
1992 1995
1998
Less than 50% 50 to 55% More than 55% State did not par ti cipate in survey
*Body mass index of 25.0 kg/m2or greater. Source: Behavioral Risk Factor Surveillance System, CD-ROM (1984-1995,
1998) and Public Use Data Tape (2004, 2006), National Center for Chronic Disease Prevention and Health Promotion,Centers for Disease Control and Prevention, 1997, 2000, 2005, 2007.
2006
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 35/78
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 36/78
Trends in Obesity* Prevalence (%), By Gender, AdultsAged 20 to 74, US, 1960-2006†
*Obesity is defined as a body mass index of 30 kg/m2 or greater. † Age adjusted to the 2000 US standard population. Source:National Health Examination Survey 1960-1962, National Health and Nutrition Examination Survey, 1971-1974, 1976-1980,
1988-1994, 1999-2002, National Center for Health Statistics, Centers for Disease Control and Prevention, 2002, 2004. 2003-2004, 2005-2006: National Health and Nutrition Examination Survey Public Use Data Files, 2003-2004, 2005-2006, NationalCenter for Health Statistics, Centers for Disease Control and Prevention, 2006, 2007.
13
11
1615
12
1715
13
17
23
21
26
31
28
343332
353534
36
0
5
10
15
20
25
30
35
40
45
Both sexes Men Women
P r e v a
l e n c e ( % )
NHES I (1960-62) NHANES I (1971-74) NHANES II (1976-80) NHANES III (1988-94)
NHANES 1999-2002 NHANES 2003-2004 NHANES 2005-2006
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 37/78
Trends in Overweight* Prevalence (%), Children andAdolescents, by Age Group, US, 1971-2004
*Overweight is defined as at or above the 95th percentile for body mass index by age and sex based onreference data.Source: National Health and Nutrition Examination Survey, 1971-1974, 1976-1980, 1988-1994, 1999-2002,National Center for Health Statistics, Centers for Disease Control and Prevention, 2002, 2004. 2003-2004: OgdenCL, et al. Prevalence of Overweight and Obesity in the United States, 1999-2004. JAMA 2006; 295 (13): 1549-55.
54
65
7
5
7
11 1110
16 16
14
19
17
0
5
10
15
20
2 to 5 years 6 to 11 years 12 to 19 years
P r e v a l e n c e ( % )
NHANES I (1971-74) NHANES II (1976-80) NHANES III (1988-94)
NHANES 1999-2002 NHANES 2003-2004
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 38/78
Obesit y does not give muchchance t o survive t o 100
A study of body height andbody build of centenarians
when they were youngadults (aged 30) using
WWI civil draft registration
cards.Gavrilova N.S., Gavrilov L.A. Can exceptionallongevity be predicted? Contingencies [Journal of theAmerican Academy of Actuaries], 2008, July/August
issue, pp. 82-88.
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 39/78
Result s of mult ivar iate study
Medium height vs shortand tall height
1.35 0.260
Slender and mediumbuild vs st out build
2.63* 0.025
Farming 2.20* 0.016
Marr ied vs unmarr ied 0.68 0.268
Nat ive born vs foreign b. 1.13 0.682
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 40/78
Estimated 2-yearprobability of dying(confidence intervals)for obese and nonobese
men and women aged70 and older: AHEAD1993–1998 (a blacksquare representsobese individuals, anda white box representsnonobese individuals).
Reynolds S L et al. The Gerontologist 2005;45:438-444
The Gerontological Society of America
Controversy of obesity:Obesity may be beneficial at older ages at least for men
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 41/78
Smoking Kil ls, Obesit y Disables:A Mult istate Approach of t he US Health and Reti rement Survey
Adult s aged 55+
Source: Reuser, Bonneux , Wil lekens. Obesity , 2009.
Men Women
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 42/78
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 43/78
I s Calor ic Rest r ict ion an Answ er t o theObesit y Epidemic at Older Ages?
“Dietary restriction in rodents has not been shown to beeffective when started in older rodents. Weight loss inhumans over 60 years of age is associated with
increased mortality, hip fracture and increasedinstitutionalization. Calorie restriction in older personsshould be considered experimental and potentiallydangerous. Exercise at present appears to be apreferable t reat ment for older persons.”
Professor John E. Morley is an authorityin geriatric medicine
John E. Morley et al., Current Opinion inClinical Nutrition and Metabolic Care
(2010):
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 44/78
Trends in Prevalence (%) of No Leisure-Time Physical Activity,by Educational Attainment, Adults 18 and Older, US, 1992-2006
Note: Data from participating states and the District of Columbia were aggregated to represent the UnitedStates. Educational attainment is for adults 25 and older.Source: Behavioral Risk Factor Surveillance System CD-ROM (1984-1995, 1996, 1998) and Public Use Data Tape(2000, 2002, 2004, 2005, 2006), National Center for Chronic Disease Prevention and Health Promotion, Centers
for Disease Control and Prevention, 1997, 1999, 2000, 2001, 2003, 2005, 2006, 2007.
0
5
10
15
20
2530
35
40
45
50
55
60
1 9 9 2
1 9 9 4
1 9 9 6
1 9 9 8
2 0 0 0
2 0 0 2
2 0 0 3
2 0 0 4
2 0 0 5
2 0 0 6
Year
P r e v a l e n c e ( % )
Adults with less than a high school education
All adults
Slow improvement in physical activity among U.S. adults
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 45/78
Changes in Diet
Both good and bad t rends On one hand, improvement in food
safety and qualit y. Bet t er aw areness
t hat f ru it s and veggies are usefu l forhealth
On t he other hand, more salt andsugar in f ood and beverages. Higherconsum pt ion of carbs increases r iskof diabetes
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 46/78
Note: Data from participating states and the District of Columbia were aggregated to represent the UnitedStates.Source: Behavioral Risk Factor Surveillance System CD-ROM (1984-1995, 1996, 1998) and Public Use Data Tape
(2000, 2003, 2005), National Center for Chronic Disease Prevention and Health Promotion, Centers for DiseaseControl and Prevention, 1997, 1999, 2000, 2001, 2004, 2006.
24.2 24.4 24.1 24.4 23.6 24.3
0
5
10
15
20
25
30
35
1994 1996 1998 2000 2003 2005
Year
P r e v a l e n
c e ( % )
Trends in Consumption of Five or More RecommendedVegetable and Fruit Servings for Cancer Prevention,
Adults 18 and Older, US, 1994-2005
Soda/cola Sweetened fruit drinks
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 47/78
3541
81
143
13 14
36 38
26
57
40
99
20
3540 39
119
99
128
69
614 11
25
10 93
91 1 1 1
0
20
40
60
80
100
120
140
1965 1977 1988 2002
p e r c a p i t
a c a l o r i e s p e r d a y
Soda/cola Sweetened fruit drinksAlcohol 100% Fruit juiceWhole-fat milk Low-fat milkCoffee Tea
. Per Capita Calories Consumed from Different Beverages by U.S.Adults (age 19 and older), 1965-2002.
Source: Nationwide Food Consumption Surveys (1965, 1977-78) and NHANES
(1988-94, 1999-02); Duffey & Popkin, Obesity (Silver Spring) 2007
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 48/78
Age-Adjusted Trends in Macronutrients and Total Calories Consumed by U.S.Adults (20-74 years), 1971-2004.
Source: National Center for Health Statistics. Health, United States 2008, With Special Focus on Young Adults. NCHS; 2009
36.9
33.436.1
33.8
42.4
48.2
45.4
50.6
20.7
18.4 18.5 15.6
0
10
20
30
40
50
1971-1974 2001-2004 1971-1974 2001-2004
p e r c e n t e n e r g y
0
500
1000
1500
2000
2500
t o t a l k c a l p e r d a y
Fat Carbohydrate Protein Calories
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 49/78
Risk of Flu and Pandemics
Olshansky SJ, Ault, A.B. The Fourt h St age of t heEpidemiologic Transit ion: The Age of DelayedDegenerat ive Diseases. The Milbank Quarterly, Vol. 64,No. 3 (1986), pp. 355-391.
Olshansky SJ, Carnes BA, Rogers RG, Smith L. Emerginginfect ious diseases: t he fif t h st age of t heepidemiological t ransit ion? World Health StatisticsQuarterly 1998;51:207-17.
Barrett R, Kuzawa CW, McDade T, Armelagos GJ.Emerging and re-emerging infect ious diseases: t hethird epidemiologic t ransit ion. Annual Review of Anthropology 1998;27:247-71.1
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 50/78
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 51/78
Grow th of Health Care Costs
May decrease usage of healt h care
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 52/78
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 53/78
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 54/78
Current t rend
Widening socioeconomicinequalit ies in mort alit y
“ I n most [ studied] count ries, mortal i t y fromcardiovascular diseases declined
proport ionally faster in t he uppersocioeconom ic groups.” (Mackenbach et al.,
2003)
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 55/78
Current view “ …mortality improvement rates for UK adults across
all ages have reached more than 2% a year - mainlydriven by a decrease in the number of peoplesmoking and the healthcare industry's effectivenessin reducing premature deaths, particularly from heart
disease. However, …both of these trends have diminishing
returns in improving mortality, as smoking rateshave already dropped to low proportions and the
decline in premature deaths related tocardiovascular disease treatments is slowing down.”
Risk Management Solutions (Global Pensions - 12 Jul2010)
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 56/78
We considered factors
af fect ing gradual changes inlife expectancy af t er age 50
What about t he opport unit y ofradical increase in survival?
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 57/78
Longevit y Revolut ion t hrough
Biotechnology and genet ic
engineering
"... it may soon be
possible to delay both aging and age-related disease in humans." (p. 162)
The Longevity Revolution: The Benefits and Challenges of Living a Long Life . By Robert N. Butler. 553pp. New York, PublicAffairs, 2008
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 58/78
Longevit y Revolut ion ( 2)
"The present level of development of aging
and longevity research justifies an Apollo-type effort to control aging ...” (p. 187)
L it R l t i ( 3)
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 59/78
Longevit y Revolut ion ( 3)
"Enthusiasts over the future of cell, tissue, and organ replacement imagine successive,
comprehensive reconstitutions of the body.Replacement or regenerative medicine would push death back, presumably indefinitely.“ (p. 401)
L it R l t i ( 4)
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 60/78
Longevit y Revolut ion ( 4)
" "Indeed, some believe that humans can master their evolution. Among them is
of Cambridge University, who suggests a life expectancy of
five thousand years by 2100 [17].“ (pp. 13-14)
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 61/78
New academic j ournal on
life-extension and rejuvenat ion
Ful ly indexed by
MEDLI NE
Latest I mpact
Factor* is 4.138
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 62/78
Why Longevit y Revolut ion m ay be delayed?
Because it requires serious funding
and commitment :
It is sheer foolishness to imagine that we can extend life ... without substantial governmental participation"
(p. 11)
“… in 2007 only about 15 to 20 percent of approved grants were funded, depending on the institute. I
believe that at least 30 percent of approved grants (if not more) should be funded. ... When funds are tight,review committees act too cautiously and conservatively. Funds should be available to support
risky research.“ (p.106)
Wh L it R l t i b d l d?
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 63/78
Why Longevit y Revolut ion m ay be delayed?(2)
“Today less than 1 percent of the entire federal budget is spent on medical research. Both to improve health and control costs, I propose that 3 percent of the nation's overall health bill ($1.8
trillion projected as 2005) or $54 billion be available to NIH for medical research from federal revenues. I also propose that of Medicare expenditures, 1 percent (or $3 billion) be devoted to the National Institute on Aging. (p.110)
Wh L it R l t i b d l d?
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 64/78
Why Longevit y Revolut ion m ay be delayed?(3)
“While the numbers I am suggesting may seem extraordinary, I believe the level of scientific progress in the field since the 1950s justifies such a program, which could be dubbed the Apollo
Program for Aging and Longevity Science.“ (p.110)
" An orbital jump in financing of science is required
to advance longevity and health as well as national wealth .“ (p. 118 - 119)
Reference: The Longevity Revolution: The Benefits and Challenges of Living a LongLife. By Robert N. Butler. 553 pp. New York, PublicAffairs, 2008
G l P di t i
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 65/78
General Predict ion
Effective life-extending technologies may appear within our
lifetime
However they will be initially expensive and not readilyavailable
Therefore, 'longevity risk' will be particularly high for persons
who are HEWM: Healthy (at baseline)
Educated
Wealthy
Motivated
It is conceivable that such HEWM people may reach lifeexpectancy of about 120 years in a foreseeable future.
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 66/78
Acknowledgments
This study w as made possiblethanks t o:
generous support from t heNat ional I nst it ut e on Aging, and
st imulat ing w orking environmentat t he Cent er on Aging,NORC/ Universit y of Chicago
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 67/78
For More I nformat ion and UpdatesPlease Visit Our
Scient if ic and Educat ional Websit eon Human Longevit y:
ht tp:/ / longevity-science.org
And Please Post Your Comment s at
our Scient if ic Discussion Blog:
ht t p:/ / longevit y-science.blogspot .com/
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 68/78
How can w e improve t he actuarial
forecast s of mort alit y and longevit y ?
By taking int o account t he mort alit y law ssummarizing prior experience in mort alit y
changes over age and t ime:
Alt hough age-specif ic mort alit y profiles
for separate causes of death are complexmort alit y f rom all causes demonst ratesrather simple behavior
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 69/78
The Gompert z-Makeham Law
A – Makeham term or background mortality
R e αx – age-dependent mortality; x - age
Death rate is a sum of age-independent component
(Makeham term) and age-dependent component
(Gompertz function), which increases exponentially
with age.
risk of death
Gompert z-Makeham Law of Mort alit y in
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 70/78
Gompert z Makeham Law of Mort alit y inI t al ian Women
Based on the officialItalian period life tablefor 1964-1967.
Source: Gavrilov,Gavrilova, “The Biology of Life Span ” 1991
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 71/78
How can t he Gompert z-Makeham law be used?
By studying t he historical
dynamics of t he mortalit ycomponent s in t his law :
Makeham component Gompertz component
Histor ical Changes in Mort ali t y
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 72/78
Histor ical Changes in Mort ali t ySwedish Females
Age
0 20 40 60 80 100
L o g ( H a z a r d R a
t e )
0.0001
0.001
0.01
0.1
1
1925196019801999
Data source : Human Mortality Database
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 73/78
Extension of t he Gompert z-Makeham
Model Through t heFactor Analysis of Mort alit y Trends
Mortality force (age, time) =
= a0(age) + a1(age) x F1( t ime) + a2(age) x F2( t ime)
Factor Analysis of Mort alit y
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 74/78
Factor Analysis of Mort alit ySw edish Females
Year
1900 1920 1940 1960 1980 2000
F a c t o r s c o r e
-2
-1
0
1
2
3
4 Factor 1 ('young ages')Factor 2 ('old ages')
Data source : Human Mortality Database
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 75/78
Implications
Mort alit y t rends before the 1950s
are useless or even misleading forcur rent forecast s because all t he“ ru les of t he game” has beenchanged
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 76/78
Preliminary Conclusions
There was some evidence for ‘ biological’mortalit y l imit s in t he past , but t hese‘limit s’ proved t o be responsive t o t herecent t echnological and medical progress.
Thus, there is no convincing evidence forabsolute ‘biological’ mort alit y l imit s now .
Analogy for il lust rat ion and clarif ication: There w as
a limit t o the speed of airplane flight in t he past ( ‘sound’barrier) , but it w as overcome by furt her technologicalprogress. Sim ilar observations seems to be applicable tocurrent human m ortalit y decline.
8/8/2019 Gavrilov-Longevity in the 21st Century
http://slidepdf.com/reader/full/gavrilov-longevity-in-the-21st-century 77/78